Nuvola G.; Dall'Olio F.G.; Melotti B.; Sperandi F.; Ardizzoni A., Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect, «JOURNAL OF THORACIC ONCOLOGY», 2019, 14, pp. e145 - e146 [Scientific article]
Capizzi E.; Dall'Olio F.G.; Gruppioni E.; Sperandi F.; Altimari A.; Giunchi F.; Fiorentino M.; Ardizzoni A., Clinical significance of ROS1 5’ deletions in non-small cell lung cancer, «LUNG CANCER», 2019, 135, pp. 88 - 91 [Scientific article]
Francesco Gelsomino,Giancarlo Facchini, Maria Aurelia Barbera,
Giuseppe Lamberti, Stefano Brocchi, Giuseppe Rossi,
Andrea Ardizzoni, Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2019, 14, pp. 141 - 143 [Scientific article]
Cho B.C.; Obermannova R.; Bearz A.; McKeage M.; Kim D.-W.; Batra U.; Borra G.; Orlov S.; Kim S.-W.; Geater S.L.; Postmus P.E.; Laurie S.A.; Park K.; Yang C.-T.; Ardizzoni A.; Bettini A.C.; de Castro G.; Kiertsman F.; Chen Z.; Lau Y.Y.; Viraswami-Appanna K.; Passos V.Q.; Dziadziuszko R., Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study, «JOURNAL OF THORACIC ONCOLOGY», 2019, 14, pp. 1255 - 1265 [Scientific article]
Cinausero, M.; Rihawi, K.; Cortiula, F.; Follador, A.; Fasola, G.; Ardizzoni, A., Emerging therapies in malignant pleural mesothelioma, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2019, 144, Article number: 102815 , pp. 1 - 9 [Scientific article]Open Access
Fumarola C.; Bozza N.; Castelli R.; Ferlenghi F.; Marseglia G.; Lodola A.; Bonelli M.; La Monica S.; Cretella D.; Alfieri R.; Minari R.; Galetti M.; Tiseo M.; Ardizzoni A.; Mor M.; Petronini P.G., Expanding the arsenal of FGFR inhibitors: A novel chloroacetamide derivative as a new irreversible agent with anti-proliferative activity against FGFR1-amplified lung cancer cell lines, «FRONTIERS IN ONCOLOGY», 2019, 9, Article number: 179 , pp. 1 - 12 [Scientific article]Open Access
Urbini, Milena; Indio, Valentina; Tarantino, Giuseppe; Ravegnini, Gloria; Angelini, Sabrina; Nannini, Margherita; Saponara, Maristella; Santini, Donatella; Ceccarelli, Claudio; Fiorentino, Michelangelo; Vincenzi, Bruno; Fumagalli, Elena; Casali, Paolo Giovanni; Grignani, Giovanni; Pession, Andrea; Ardizzoni, Andrea; Astolfi, Annalisa*; Pantaleo, Maria Abbondanza, Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST, «GENES, CHROMOSOMES & CANCER», 2019, 58, pp. 636 - 642 [Scientific article]Open Access
Pantaleo M.A.; Tarantino G.; Agostinelli C.; Urbini M.; Nannini M.; Saponara M.; Castelli C.; Stacchiotti S.; Fumagalli E.; Gatto L.; Santini D.; De Leo A.; Marafioti T.; Akarca A.; Sabattini E.; pession A.; Ardizzoni A.; Indio V.; Astolfi A., Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response, «ONCOIMMUNOLOGY», 2019, 8, Article number: e1617588 , pp. e1617588 - e1617588-10 [Scientific article]
Crino, L.; Bidoli, P.; Delmonte, A.; Grossi, F.; De Marinis, F.; Ardizzoni, A.; Vitiello, F.; Lo Russo, G.; Parra, H. S.; Cortesi, E.; Cappuzzo, F.; Calabro, L.; Tiseo, M.; Turci, D.; Gamucci, T.; Antonelli, P.; Morabito, A.; Chella, A.; Giannarelli, D.; Galetta, D., Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population, «THE ONCOLOGIST», 2019, 24, pp. e1165 - e1171 [Scientific article]
Cinausero M.; Laprovitera N.; Maglio G.D.; Gerratana L.; Riefolo M.; Macerelli M.; Fiorentino M.; Porcellini E.; Buoro V.; Gelsomino F.; Squadrilli A.; Fasola G.; Negrini M.; Tiseo M.; Ferracin M.; Ardizzoni A., KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2019, 11, Article number: 1758835919885540 , pp. 1 - 13 [Scientific article]Open Access
Rihawi, Karim; Alfieri, Roberta; Fiorentino, Michelangelo; Fontana, Francesca; Capizzi, Elisa; Cavazzoni, Andrea; Terracciano, Mario; La Monica, Silvia; Ferrarini, Alberto; Buson, Genny; Petronini, Pier Giorgio; Ardizzoni, Andrea, MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report, «TRANSLATIONAL ONCOLOGY», 2019, 12, pp. 116 - 121 [Scientific article]Open Access
Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F, New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes., «CLINICAL GENITOURINARY CANCER», 2019, 1, pp. E871 - E877 [Scientific article]
Di Nunno, Vincenzo; Mollica, Veronica; Santoni, Matteo; Gatto, Lidia; Schiavina, Riccardo; Fiorentino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco, New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 871 - 877 [Scientific article]
Raschi E, Antonazzo IC, La Placa M, Ardizzoni A, Poluzzi E, De Ponti F., Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System., «THE ONCOLOGIST», 2019, 24, pp. e1228 - e1231 [Scientific article]
Mazzaschi, Giulia; Facchinetti, Francesco; Missale, Gabriele; Canetti, Diana; Madeddu, Denise; Zecca, Alessandra; Veneziani, Michele; Gelsomino, Francesco; Goldoni, Matteo; Buti, Sebastiano; Bordi, Paola; Aversa, Franco; Ardizzoni, Andrea; Quaini, Federico; Tiseo, Marcello, The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC, «LUNG CANCER», 2019, 127, pp. 153 - 163 [Scientific article]
